SCHEMBL19081674

SCHEMBL19081674

CC1(C)c2ccccc2-c2ccc(-c3c4ccccc4c(-c4ccc5oc6cc7c(cc6c5c4)oc4ccc5ccccc5c47)c4ccccc34)cc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 5/20 0.34
AHR P35869 3/20 0.33
KMT2A Q03164 3/20 0.33
NPC1 O15118 3/20 0.33
PAX8 Q06710 2/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
RAB9A P51151 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1A2 P05177 1/20 0.33
FYN P06241 1/20 0.33
MAPK3 P27361 1/20 0.33
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17931986 0.97 ABCG2 (0.36) ABCG2AHRKMT2ANPC1PAX8
SCHEMBL20127310 0.94 ABCG2 (0.34) ABCG2AHRKMT2ANPC1PAX8
SCHEMBL20127316 0.93 ABCG2 (0.34) ABCG2AHRKMT2ANPC1PAX8
SCHEMBL19080999 0.92 ABCG2 (0.35) ABCG2AHRKMT2ANPC1PAX8
SCHEMBL19081679 0.92 ABCG2 (0.33) ABCG2AHRKMT2ANPC1PAX8
SCHEMBL20127575 0.91 ABCG2 (0.35) ABCG2AHRKMT2ANPC1PAX8
SCHEMBL19081672 0.91 ABCG2 (0.33) ABCG2AHRKMT2ANPC1PAX8
SCHEMBL10122702 0.90 ABCG2 (0.34) ABCG2AHRKMT2ANPC1PAX8
SCHEMBL10122700 0.90 ABCG2 (0.34) ABCG2AHRKMT2ANPC1PAX8
SCHEMBL21729922 0.90 ABCG2 (0.36) ABCG2AHRKMT2ANPC1PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885AHR 2453/4885KMT2A 1773/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885AHR 2453/4885KMT2A 1773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.